| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.105 | 45.847 | 49.890 | 73.749 | 90.475 | 71.997 | 91.932 | 94.335 | 81.291 | 0 |
| Total Income - EUR | 43.472 | 45.847 | 49.890 | 81.057 | 90.705 | 71.999 | 91.934 | 94.336 | 81.292 | 1 |
| Total Expenses - EUR | 39.628 | 47.846 | 45.999 | 61.245 | 71.115 | 58.420 | 53.598 | 63.810 | 49.675 | 7.232 |
| Gross Profit/Loss - EUR | 3.844 | -1.999 | 3.891 | 19.812 | 19.590 | 13.579 | 38.335 | 30.526 | 31.618 | -7.231 |
| Net Profit/Loss - EUR | 2.540 | -2.457 | 3.393 | 19.001 | 18.683 | 12.911 | 37.434 | 29.602 | 30.193 | -7.231 |
| Employees | 4 | 4 | 5 | 4 | 4 | 3 | 3 | 3 | 2 | 0 |
Check the financial reports for the company - Medicat Medfam Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.667 | 7.510 | 2.918 | 22.869 | 17.575 | 10.638 | 3.699 | 639 | 1.986 | 1.496 |
| Current Assets | 2.988 | 3.722 | 4.377 | 17.341 | 28.300 | 10.916 | 7.776 | 34.023 | 29.104 | 14 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.954 | 3.415 | 3.610 | 5.567 | 5.538 | 75 | 7.448 | 22.709 | 23.257 | 0 |
| Cash | 1.034 | 306 | 767 | 11.775 | 22.763 | 10.840 | 328 | 11.314 | 5.848 | 14 |
| Shareholders Funds | 8.810 | -2.413 | 1.021 | 20.003 | 38.299 | 15.665 | 6.202 | 29.650 | 30.242 | -285 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.845 | 13.645 | 6.274 | 20.207 | 7.577 | 5.888 | 5.272 | 5.012 | 849 | 1.795 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicat Medfam Srl